Streamlining of Indian supply chain needed to cut costs
Rising use of biologics and a tax initiative will drive the streamlining of Indian supply chains, helping companies to deliver drugs at affordable prices, according to PwC.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs